Posted by Michael Wonder on 17 Dec 2020
Update on assessment of marketing authorisation application for Moderna’s mRNA-1273 COVID-19 vaccine
17 December 2020 - Over the last few weeks, EMA has made good progress on the assessment of the marketing authorisation application for Moderna’s mRNA-1273 COVID-19 vaccine.
A continuous dialogue with the company has ensured that questions that arose during the evaluation were swiftly followed up and addressed by the company.
